Cubic Health Monthly

November/December 2011 – The Shortcoming of Mandatory Generic Substitution

IN THIS ISSUE...Under the microscope: are plans overpaying for newer therapies for Diabetes...Biosimilar Chorionic Gonadotropin in Quebec – Clarification...NOC Watch: Sublinox, Generic Latanoprost...FEATURE: The Story of Nexium®, Generic Esomeprazole and the Shortcoming of Mandatory Generic Substitution...Subsequent Entry Biologics: Expectations and Reality View post


September/October 2011 – Hepatitis C treatment costs expected to double

IN THIS ISSUE...FEATURE: Breakthrough in the treatment of hepatitic C: treatment costs expected to more than double...Aspirin Falling Out of Favour?...NOC Watch: OxyNEO, Staxyn...Toromont Industries Recognized as a Finalist for the Inaugural Benefits Canada Drug Plan Management Award. View post


July/August 2011 – Money down the drain – nobody benefits from non-adherence

IN THIS ISSUE...Under the microscope: are plans overpaying for newer therapies for Diabetes...Biosimilar Chorionic Gonadotropin in Quebec – Clarification...NOC Watch: Jevtana, Generic Zolmitriptan, Benlysta...FEATURE: Money down the drain - nobody benefits from non-adherence View post


May/June 2011 – Carpe Diem: Savings with Generics, and Drug Plans or Dealer Supply Chains

IN THIS ISSUE...HIV treatment: earlier is better...NOC Watch: Abstral, Gelnique...FEATURES: Carpe Diem – Savings with Generics in 2011...Drug plans or dealer supply chains? View post


March/April 2011 – Benefits Intelligence: The need for data-mining in benefit plans

IN THIS ISSUE...Breakthrough in Multiple Sclerosis treatment...NOC Watch: Vimovo, Revolade...FEATURE: Benefits Intelligence: The need for data-mining in benefit plans...Highlights from Cubic Health's February presentations View post


Latest News